Skip to main content
. 2023 May 4;28(10):e930–e941. doi: 10.1093/oncolo/oyad121

Table 4.

Severity of COVID-19 infection in patients with CLL and other indolent NHLs.

NIH clinical spectrum All patients (n = 30) CLL (n = 22) WM and other NHLs (n = 8)
Asymptomatic infection 3% (1/30) 13% (1/8)
Mild/moderate illness 70% (21/30) 77% (17/22) 50% (4/8)
Severe illness 17% (5/30) 14% (3/22) 25% (2/8)
Critical illness 10% (3/30) 9% (2/22) 13% (1/8)
COVID-19 deaths 7% (2/30) 9% (2/22)